anti-beta folate receptor mAbs (Purdue University)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug Nameanti-beta folate receptor mAbs (Purdue University)
Drug Alias NameFolate-ArthritisFolieffolate-targeted imaging agents (Endocyte/Purdue University)folate-targeted therapeutics (Endocyte)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanDiagnostic agent (In vivo)
Mechanisms of ActionFolate receptor beta antagonists
TargetsFolate receptor beta
Therapy Area/IndicationsInflammationArthritis, RheumatoidNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPurdue University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPurdue UniversityEndocyte Inc
Active IndicationsN/A
Inactive IndicationsInflammationArthritis, RheumatoidNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A